Mito Technology

Mito Technology company information, Employees & Contact Information

Explore related pages

Related company profiles:

MITO Technology is the advisor to venture capital funds aiming to drive radical transformation in society toward a more sustainable future. We started as a platform to support public-to-private technology transfer, and over the last 15 years we have become an active player in the European innovation ecosystem — collaborating with multinationals, SMEs, universities, research centers, startups, spin-offs, banks, VC and PE funds. With a multidisciplinary team combining expertise in deep tech, technology transfer, innovation finance, and IP management, our model has evolved over time. In 2018, we sponsored and began advising Progress Tech Transfer (now MITO Tech Transfer) — the first VC fund in Italy entirely focused on sustainability technologies. Building on the success of the first, in 2024 we launched a more ambitious initiative: MITO Tech Ventures, one of the first early-stage climate tech funds in Europe compliant with Article 9 of the SFDR regulation. Both funds — MITO Tech Transfer and MITO Tech Ventures — are RAIFs (Reserved Alternative Investment Funds) under the laws of the Grand Duchy of Luxembourg, with an external AIFM.

Company Details

Employees
13
Founded
-
Address
Largo Guido Donegani, 2, Milan,lombardy 20121,italy
Phone
+39 02 29413168
Email
in****@****tech.eu
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
Milan, Lombardy
Looking for a particular Mito Technology employee's phone or email?

Mito Technology Questions

News

Mitotech Presents Promising Results in Friedreich's Ataxia - PRWeb

Mitotech Presents Promising Results in Friedreich's Ataxia PRWeb

Mitotech: a Dry Eye treatment aimed at mitochondria - Fierce Biotech

Mitotech: a Dry Eye treatment aimed at mitochondria Fierce Biotech

Mitotech granted Orphan Drug Designation by FDA for Visomitin in LHON - Ophthalmology Times

Mitotech granted Orphan Drug Designation by FDA for Visomitin in LHON Ophthalmology Times

Mito Tech Ventures, Mito Technology’s new climatech fund - Startupbusiness.it

Mito Tech Ventures, Mito Technology’s new climatech fund Startupbusiness.it

Mitotech’s SkQ1 targets mtROS, and a long list of age-related diseases - Fierce Biotech

Mitotech’s SkQ1 targets mtROS, and a long list of age-related diseases Fierce Biotech

Mitotech: a (very) different approach to treating Dry Eye - Fierce Biotech

Mitotech: a (very) different approach to treating Dry Eye Fierce Biotech

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant